
Becton, Dickinson and Company BDX
€ 168.83
-0.3%
Geschäftsbericht 2025
hinzugefügt 25.11.2025
Becton, Dickinson and Company DSO 2011-2026 | BDX
DSO Jährlich Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.4 | 50.4 | 44.5 | 43.9 | 45.3 | 53.9 | 49.5 | 53 | 52.6 | 47.3 | 57.4 | 51.3 | 56.2 | 59.2 | 57.3 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 59.2 | 43.9 | 51.5 |
DSO Vierteljährlich Becton, Dickinson and Company
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.5 | 49 | 46.2 | 47.1 | 43.6 | 45.4 | 45.1 | 44.4 | 44.5 | - | 22.6 | 43 | 45.2 | - | 42.7 | 45.2 | 40.9 | 45.7 | 56.8 | 38.4 | 47.7 | 46.7 | 49.2 | 49.2 | 49.7 | 48.1 | 49.5 | 46.7 | 55.5 | 50.3 | 52.4 | 50.1 | 49 | 45.7 | 45.5 | 48.2 | 47.8 | 48.7 | 47.7 | 40.5 | 49.3 | 49.2 | 50.2 | 51.2 | 53.3 | 19 | 55.1 | 54.5 | 58 | 19.9 | 57.6 | 57.4 | 59 | 20 | 57.4 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 59 | 19 | 46.7 |
DSO anderer Aktien in der Medizinische Instrumente
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
0.0506 | - | - | $ 810 M | ||
|
Baxter International
BAX
|
204 | $ 19.66 | 0.25 % | $ 10 B | ||
|
Luminex Corporation
LMNX
|
58.6 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
9.92 | - | -9.52 % | $ 20.6 M | ||
|
Antares Pharma, Inc.
ATRS
|
123 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
65.5 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
91.1 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
75.4 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
123 | - | -0.02 % | $ 16.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
131 | $ 8.19 | -3.65 % | $ 165 M | ||
|
Alcon
ALC
|
71 | $ 81.06 | 0.8 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
44.3 | $ 36.8 | -2.57 % | $ 1.73 B | ||
|
Haemonetics Corporation
HAE
|
54.9 | $ 65.68 | -0.58 % | $ 3.31 B | ||
|
electroCore
ECOR
|
12.7 | $ 7.29 | 0.55 % | $ 40.2 K | ||
|
AngioDynamics
ANGO
|
54 | $ 9.97 | -0.4 % | $ 407 M | ||
|
ICU Medical
ICUI
|
26.4 | $ 148.97 | -0.21 % | $ 3.63 B | ||
|
InfuSystem Holdings
INFU
|
53.6 | $ 8.09 | -0.12 % | $ 167 M | ||
|
The Cooper Companies
COO
|
68.9 | $ 80.1 | -0.48 % | $ 15.9 B | ||
|
Harvard Bioscience
HBIO
|
53.3 | $ 0.54 | -5.75 % | $ 22.9 M | ||
|
Glaukos Corporation
GKOS
|
44 | $ 119.43 | -3.64 % | $ 5.78 B | ||
|
Repro Med Systems
KRMD
|
48.7 | $ 5.44 | -1.45 % | $ 248 M | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
43.6 | $ 148.84 | -1.98 % | $ 4.64 B | ||
|
LeMaitre Vascular
LMAT
|
43.2 | $ 83.83 | -1.45 % | $ 1.88 B | ||
|
Masimo Corporation
MASI
|
12.7 | $ 136.05 | -1.18 % | $ 7.25 B | ||
|
Merit Medical Systems
MMSI
|
49.5 | $ 80.26 | -0.3 % | $ 4.67 B | ||
|
Intuitive Surgical
ISRG
|
51.5 | $ 506.31 | -3.01 % | $ 180 B | ||
|
NeuroMetrix
NURO
|
42.8 | - | 5.05 % | $ 9.02 M | ||
|
Microbot Medical
MBOT
|
167 | $ 1.84 | -3.42 % | $ 18.8 M | ||
|
Nephros
NEPH
|
35.7 | $ 4.36 | -3.33 % | $ 45.3 M | ||
|
Milestone Scientific
MLSS
|
16.7 | $ 0.3 | 3.66 % | $ 23.9 M | ||
|
Envista Holdings Corporation
NVST
|
56 | $ 23.44 | -2.66 % | $ 4.04 B | ||
|
OraSure Technologies
OSUR
|
62.8 | $ 2.78 | 2.78 % | $ 207 M | ||
|
Pro-Dex
PDEX
|
83.1 | $ 39.1 | -0.81 % | $ 129 M | ||
|
Predictive Oncology
POAI
|
115 | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
15.9 | $ 13.48 | -0.52 % | $ 648 M | ||
|
Repligen Corporation
RGEN
|
69.4 | $ 155.32 | -2.96 % | $ 8.65 M | ||
|
ResMed
RMD
|
60.7 | $ 257.93 | 0.08 % | $ 37.7 B | ||
|
STERIS plc
STE
|
68.6 | $ 261.03 | 0.07 % | $ 25.7 B | ||
|
BioLife Solutions
BLFS
|
37.9 | $ 22.71 | -1.0 % | $ 1.05 B | ||
|
Stereotaxis
STXS
|
60.8 | $ 2.33 | -6.43 % | $ 188 M | ||
|
Retractable Technologies
RVP
|
102 | $ 0.7 | - | $ 21 M | ||
|
STAAR Surgical Company
STAA
|
100 | $ 18.97 | -0.97 % | $ 932 M | ||
|
Utah Medical Products
UTMD
|
132 | $ 61.0 | 0.26 % | $ 221 M | ||
|
Teleflex Incorporated
TFX
|
54.1 | $ 105.27 | -0.06 % | $ 4.93 B | ||
|
West Pharmaceutical Services
WST
|
67.1 | $ 230.25 | -2.39 % | $ 16.8 B | ||
|
DENTSPLY SIRONA
XRAY
|
64.3 | $ 12.24 | -0.61 % | $ 2.49 B |